3.30
price down icon2.65%   -0.09
after-market After Hours: 3.21 -0.09 -2.73%
loading
Cellectar Biosciences Inc stock is traded at $3.30, with a volume of 52,493. It is down -2.65% in the last 24 hours and down -42.91% over the past month. Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.
See More
Previous Close:
$3.39
Open:
$3.43
24h Volume:
52,493
Relative Volume:
0.29
Market Cap:
$10.53M
Revenue:
-
Net Income/Loss:
$-37.75M
P/E Ratio:
-1.0154
EPS:
-3.25
Net Cash Flow:
$-30.91M
1W Performance:
-8.08%
1M Performance:
-42.91%
6M Performance:
+1,119%
1Y Performance:
+62.56%
1-Day Range:
Value
$3.20
$3.43
1-Week Range:
Value
$3.20
$3.61
52-Week Range:
Value
$0.224
$10.19

Cellectar Biosciences Inc Stock (CLRB) Company Profile

Name
Name
Cellectar Biosciences Inc
Name
Phone
(608) 441-8120
Name
Address
100 CAMPUS DRIVE, FLORHAM PARK, NJ
Name
Employee
11
Name
Twitter
@CellectarBio
Name
Next Earnings Date
2025-03-05
Name
Latest SEC Filings
Name
CLRB's Discussions on Twitter

Compare CLRB with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
CLRB
Cellectar Biosciences Inc
3.30 10.82M 0 -37.75M -30.91M -3.25
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.00 109.11B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
642.25 68.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
434.07 60.25B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
826.28 50.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
186.23 40.44B 447.02M -1.18B -868.57M -6.1812

Cellectar Biosciences Inc Stock (CLRB) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-05-24 Resumed Ladenburg Thalmann Buy
Jul-01-20 Initiated Oppenheimer Outperform
Jan-21-20 Resumed ROTH Capital Buy
Sep-13-19 Initiated ROTH Capital Buy
Dec-21-16 Initiated Ladenburg Thalmann Buy

Cellectar Biosciences Inc Stock (CLRB) Latest News

pulisher
09:59 AM

Will Cellectar Biosciences Inc. bounce back from current supportJuly 2025 PreEarnings & Long-Term Investment Growth Plans - newser.com

09:59 AM
pulisher
08:59 AM

Is Cellectar Biosciences Inc. stock a top pick in earnings seasonAnalyst Downgrade & Precise Swing Trade Entry Alerts - newser.com

08:59 AM
pulisher
08:53 AM

Will Cellectar Biosciences Inc. (NV4) stock deliver compounding returnsLong Setup & Risk Controlled Swing Alerts - newser.com

08:53 AM
pulisher
08:29 AM

Can Cellectar Biosciences Inc. stock hit record highs again2025 Key Highlights & AI Enhanced Trading Signals - newser.com

08:29 AM
pulisher
08:20 AM

How strong is Cellectar Biosciences Inc. (NV4) stock earnings growthJuly 2025 Summary & Real-Time Stock Price Movement Reports - newser.com

08:20 AM
pulisher
08:02 AM

Using R and stats models for Cellectar Biosciences Inc. forecastingPortfolio Update Report & Technical Confirmation Alerts - newser.com

08:02 AM
pulisher
06:31 AM

Is now a turning point for Cellectar Biosciences Inc.2025 Market WrapUp & Safe Capital Growth Tips - newser.com

06:31 AM
pulisher
06:26 AM

How analysts rate Cellectar Biosciences Inc. stock today2025 Retail Activity & Real-Time Volume Analysis - newser.com

06:26 AM
pulisher
06:22 AM

Will Cellectar Biosciences Inc. stock pay special dividendsJuly 2025 Fed Impact & Fast Gain Swing Trade Alerts - newser.com

06:22 AM
pulisher
06:12 AM

Can Cellectar Biosciences Inc. stock surprise with earnings upside2025 AllTime Highs & Consistent Return Strategy Ideas - newser.com

06:12 AM
pulisher
04:31 AM

Will Cellectar Biosciences Inc. benefit from macro trendsTrade Risk Assessment & Low Drawdown Investment Ideas - newser.com

04:31 AM
pulisher
04:03 AM

Published on: 2025-11-03 03:03:40 - newser.com

04:03 AM
pulisher
03:34 AM

How hedge fund analytics apply to Cellectar Biosciences Inc. stock2025 Key Lessons & Step-by-Step Trade Execution Guides - newser.com

03:34 AM
pulisher
03:28 AM

Why Cellectar Biosciences Inc. stock could outperform in 2025July 2025 Snapshot & Free Real-Time Market Sentiment Alerts - newser.com

03:28 AM
pulisher
02:25 AM

Using RSI to spot recovery in Cellectar Biosciences Inc.Chart Signals & Weekly High Return Stock Opportunities - newser.com

02:25 AM
pulisher
02:02 AM

Will Cellectar Biosciences Inc. stock gain from government policies2025 Valuation Update & AI Powered Market Trend Analysis - newser.com

02:02 AM
pulisher
01:57 AM

What the charts say about Cellectar Biosciences Inc. today2025 Support & Resistance & Growth Focused Stock Pick Reports - newser.com

01:57 AM
pulisher
01:47 AM

Can Cellectar Biosciences Inc. stock deliver sustainable ROEJuly 2025 Analyst Calls & Weekly Chart Analysis and Trade Guides - newser.com

01:47 AM
pulisher
01:44 AM

Using data tools to time your Cellectar Biosciences Inc. exitJuly 2025 Highlights & Weekly Breakout Opportunity Watchlist - newser.com

01:44 AM
pulisher
12:06 PM

Using data filters to optimize entry into Cellectar Biosciences Inc.Market Performance Report & AI Powered Market Entry Strategies - newser.com

12:06 PM
pulisher
Nov 02, 2025

Is Cellectar Biosciences Inc. stock a safe investment in uncertain markets2025 Price Action Summary & Free Technical Pattern Based Buy Signals - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Is Cellectar Biosciences Inc. stock a buy in volatile marketsJuly 2025 Spike Watch & Long-Term Safe Return Strategies - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

How Cellectar Biosciences Inc. (NV4) stock correlates with oil marketsWeekly Profit Summary & Fast Exit and Entry Strategy Plans - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Is Morguard Real Estate Investment Trust T0L a good long term investmentBlue Chip Stock Analysis & Free Long-Term Investment Planning - earlytimes.in

Nov 02, 2025
pulisher
Nov 02, 2025

Cellectar Biosciences Inc Stock Analysis and ForecastGeopolitical Risk Analysis & Small Capital Growth Tips - earlytimes.in

Nov 02, 2025
pulisher
Nov 02, 2025

Can Cellectar Biosciences Inc. hit a new high this month2025 Earnings Surprises & Fast Momentum Entry Tips - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Why analysts remain bullish on Cellectar Biosciences Inc. stock2025 Investor Takeaways & Weekly Momentum Picks - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Can Cellectar Biosciences Inc. stock weather global recessionGap Up & Fast Entry Momentum Trade Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Has Cellectar Biosciences Inc. found a price floor2025 Market WrapUp & Low Drawdown Investment Ideas - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Using Python tools to backtest Cellectar Biosciences Inc. strategiesQuarterly Earnings Summary & Long-Term Safe Investment Ideas - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Cellectar Biosciences, Inc. (CLRB) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK

Nov 01, 2025
pulisher
Nov 01, 2025

Published on: 2025-11-01 12:28:59 - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Published on: 2025-11-01 05:42:39 - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Is Cellectar Biosciences Inc. (NV4) stock supported by strong fundamentalsAnalyst Downgrade & Stock Portfolio Risk Control - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Published on: 2025-11-01 03:42:44 - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Will Cellectar Biosciences Inc. (NV4) stock split increase liquidity2025 Risk Factors & Expert Approved Trade Ideas - newser.com

Oct 31, 2025

Cellectar Biosciences Inc Stock (CLRB) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Cellectar Biosciences Inc Stock (CLRB) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Longcor Jarrod
Chief Operating Officer
Jul 02 '25
Buy
4.99
10,000
49,900
12,768
Kolean Chad J
Chief Financial Officer
Jul 02 '25
Buy
4.99
5,000
24,950
6,418
Longcor Jarrod
Chief Operating Officer
Jan 10 '25
Buy
0.28
30,000
8,400
83,141
$37.30
price down icon 0.64%
$28.71
price up icon 0.35%
$101.57
price up icon 8.65%
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
$186.23
price down icon 1.78%
Cap:     |  Volume (24h):